TYPE 1 DIABETES (T1D)
Approximately 1.6 million Americans are living with T1D — including more than 1.3 million adults.
T1D is an autoimmune condition in which the immune system attacks the insulin-producing cells of the pancreas, leading to little or no insulin production.
It requires lifelong insulin therapy and careful glucose monitoring. Clinical research is advancing new insulin therapies, devices, and technology, as well as approaches for earlier detection and prevention.
Something about upcoming trials in this copy block. Lorem ipsum dolor sit amet consectetur adipiscing elit nam fermentum ultrices nunc id molestie. Suspendisse faucibus vel nibh ac rutrum sednec est sit amet lacus dapibus lobortis. Etiam quis orci urna a liquam erat volutpat interdum et malesuada fames ac ante ipsum primis in faucibus.